Rapamune (sirolimus) Oral Solution and Tablets

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) November 2015 WARNINGS AND PRECAUTIONS Interstitial Lung Disease/Non-Infectious Pneumonitis In some cases, the ILD was reported...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts